Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 162

Sort by

Sort Order Select

Journal Articles

Modal CAR T cells: A synthetic cytokine circuit to overcome TGFβ-mediated immunosuppression in AML

Fuguo Liu, Xingyu Deng, Veronica Hui, Maily Nguyen, Wenxin Xu, Mubin Tarannum, Andreia Maia, Shaobo Yang, Remy Dulery, Stephanie Sendker, Alaa Ali, John Koreth, Jose Cancelas, Jianzhu Chen, Robert Soiffer, Catherine Wu, Jerome Ritz, Toni Choueiri, Rizwan Romee

Blood (2025) 146 (Supplement 1): 4096.

https://doi.org/10.1182/blood-2025-4096

Published: 2025

Journal Articles

Development of a novel multiomic sequencing approach to characterize infused donor memory-like NK cells in an immune compatible environment

Roman Shapiro, Grace Birch, Chen Weng, Jonas Gudera, Michael Poeschla, Matthew Booker, Michael Tolstorukov, Michal Sheffer, Remy Dulery, Sarah Nikiforow, John Koreth, Catherine Wu, Robert Soiffer, Jerome Ritz, Vijay Sankaran, Rizwan Romee

Blood (2025) 146 (Supplement 1): 2352.

https://doi.org/10.1182/blood-2025-2352

Published: 2025

Journal Articles

LIME: A first-in-class of live bacterial immune engagers for cancer immunotherapy

Blood (2025) 146 (Supplement 1): 264.

https://doi.org/10.1182/blood-2025-264

Published: 2025

Journal Articles

Primary results from Equator, a Phase 3 double-blind, randomized placebo-controlled study evaluating itolizumab in combination with corticosteroids as initial treatment of acute graft-versus-host disease.

John Koreth, Maria Carmen Martinez Munoz, Jeremy Pantin, Shukaib Arslan, Jaime Sanz, Alison Loren, Benedetta Rambaldi, Elisa Sala, Avichai Shimoni, Tsila Zuckerman, Corey Cutler, Lisette Acevedo, Kham Phenis, Eugene Sun, Stephen Connelly, Joel Rothman

Blood (2025) 146 (Supplement 1): 274.

https://doi.org/10.1182/blood-2025-274

Published: 2025

Journal Articles

Early TCR diversity and recipient stem-cell persistence predict relapse and reveal therapeutic targets after allogeneic transplantation

Blood (2025) 146 (Supplement 1): 6065.

https://doi.org/10.1182/blood-2025-6065

Published: 2025

Journal Articles

Reprogramming CAR-NK cells with IL-7/IL-7Rα to amplify STAT1 signaling and activate bystander T cells for enhanced immunotherapy

Blood (2025) 146 (Supplement 1): 4129.

https://doi.org/10.1182/blood-2025-4129

Published: 2025

Journal Articles

Overcoming CAR T cell resistance in NPM1c and KMT2Ar AML through menin pathway inhibition

Sara Piccinelli, Wallace Bourgeois, Andreia Maia, Eden Bobilev, Fuguo Liu, Xingyu Deng, Han Dong, Robert Soiffer, Catherine Wu, Jerome Ritz, Daniel Deangelo, Andrew Lane, Roman Shapiro, Jianzhu Chen, John Koreth, Rizwan Romee

Blood (2025) 146 (Supplement 1): 2319.

https://doi.org/10.1182/blood-2025-2319

Published: 2025

Journal Articles

Impact of graft versus host disease prophylaxis with post transplant cyclophosphamide on the prognostic value of HCT-CI

Ansh Mehta, Haesook Kim, Arcita Pramudita, Deborah Liney, Remy Dulery, Vincent Ho, Corey Cutler, John Koreth, Mahasweta Gooptu, Joseph Antin, Amar Kelkar, Sarah Nikiforow, Prashant Nageshwar, Catherine Wu, Jerome Ritz, Rizwan Romee, Robert Soiffer, Roman Shapiro

Blood (2025) 146 (Supplement 1): 4227.

https://doi.org/10.1182/blood-2025-4227

Published: 2025

Journal Articles

Effect of graft cellular content on outcomes in HLA mismatched hematopoietic cell transplantation using post-transplant cyclophosphamide

Remy Dulery, Sandra Lee, Sarah Nikiforow, Carol Reynolds, Heather Garrity, Karl Stasko, Andrew Mason, Corey Cutler, John Koreth, Mahasweta Gooptu, Joseph Antin, Amar Kelkar, Vincent Ho, Catherine Wu, Rizwan Romee, Jerome Ritz, Robert Soiffer, Roman Shapiro

Blood (2025) 146 (Supplement 1): 4260.

https://doi.org/10.1182/blood-2025-4260

Published: 2025

Journal Articles

Donor regulatory/conventional T-cell grafts for the GVHD win?

Antonio Pierini, John Koreth

Blood (2025) 145 (18): 1964–1965.

https://doi.org/10.1182/blood.2024028047

Published: 2025

Journal Articles

Impact of Consolidative Cellular Therapy with DLI or Second Transplant in Patients with AML Who Achieve Complete Remission Following Post-Transplant Relapse

H. Moses Murdock, Haesook T. Kim, Katie Maurer, Amar H. Kelkar, Roman M. Shapiro, Mahasweta Gooptu, Rizwan Romee, Corey S. Cutler, John Koreth, Jerome Ritz, Joseph H. Antin, Vincent T. Ho, Sarah Nikiforow, Catherine J. Wu, Robert J. Soiffer

Blood (2024) 144 (Supplement 1): 3538.

https://doi.org/10.1182/blood-2024-204343

Published: 2024

Journal Articles

Heterogeneity of PD-1 + regulatory T Cells after Low-Dose IL-2 Therapy for Patients with Chronic Graft-Versus-Host Disease

Blood (2024) 144 (Supplement 1): 379.

https://doi.org/10.1182/blood-2024-200128

Published: 2024

Journal Articles

Effects of GvHD Prophylaxis with Post-Transplant Cyclophosphamide on Immune Reconstitution and TCR Repertoire after Haploidentical and HLA-Matched Transplantation Compared to Prophylaxis with Calcineurin Inhibitor Plus Methotrexate in HLA-Matched Transplantation

Michela Ansuinelli, Haesook T. Kim, Carol G. Reynolds, Francesco Malfona, Shuntaro Ikegawa, Rakuyo Tamada, Roman M. Shapiro, Mahasweta Gooptu, Rizwan Romee, Sarah Nikiforow, John Koreth, Vincent T. Ho, Corey S. Cutler, Joseph H. Antin, Leslie Kean, Robert J. Soiffer, Jerome Ritz

Blood (2024) 144 (Supplement 1): 1041.

https://doi.org/10.1182/blood-2024-201835

Published: 2024

Journal Articles

Induction of Graft-Versus-Leukemia Effect with Treg-Depleted DLI Plus Ipilimumab for Myeloid Disease Relapse after HLA-Matched Transplant

Roman M. Shapiro, Haesook T. Kim, William H Terral, Vincent T. Ho, Mahasweta Gooptu, Rizwan Romee, Christopher J. Gibson, Amar H. Kelkar, Corey S. Cutler, Joseph H. Antin, Katie Maurer, Catherine J. Wu, Robert Zeiser, Jerome Ritz, Robert J. Soiffer, Sarah Nikiforow, John Koreth

Blood (2024) 144 (Supplement 1): 4833.

https://doi.org/10.1182/blood-2024-194102

Published: 2024

Journal Articles

BK Virus Reactivation and Disease after Allogeneic Hematopoietic-Cell Transplantation: A Natural History Study

Blood (2024) 144 (Supplement 1): 3500.

https://doi.org/10.1182/blood-2024-199776

Published: 2024

Journal Articles

Mesothelin Targeting IL12-Engineered CAR Memory-like NK Cells Demonstrate Promising Efficacy in Acute Myeloid Leukemia

Jieun Jang, Mila Stanojevic, Sara Piccinelli, Michal Sheffer, Grace Caroline Birch, Roman M. Shapiro, Maximilian Stahl, John Koreth, Catherine J. Wu, Robert J. Soiffer, Jerome Ritz, Mubin Tarannum, Rizwan Romee

Blood (2024) 144 (Supplement 1): 917.

https://doi.org/10.1182/blood-2024-204369

Published: 2024

Journal Articles

Early CMV Viral Load Burden Predicts Late Clinically Significant CMV Infections in Patients Receiving Ptcy-Based Hematopoietic Cell Transplantation

Jessica S. Little, Kyle Hebert, Donna S. Neuberg, Sarah Nikiforow, Mahasweta Gooptu, Roman M. Shapiro, John Koreth, Joseph H. Antin, Corey S. Cutler, Robert J. Soiffer, Jerome Ritz, Rizwan Romee, Vincent T. Ho, Nicolas C Issa, Lindsey R. Baden, Remy Dulery, Susan E Prockop

Blood (2024) 144 (Supplement 1): 4885.

https://doi.org/10.1182/blood-2024-205169

Published: 2024

Journal Articles

Redefining Clinical Response Criteria in Myelodysplastic Syndromes to Better Forecast Post-Transplant Outcomes

Blood (2024) 144 (Supplement 1): 4938.

https://doi.org/10.1182/blood-2024-209087

Published: 2024

Journal Articles

Expression of HLA-B*35 Is Associated with an Increased Risk of CMV Viremia and Clinically Significant CMV Infection in Patients Receiving Ptcy-Based Hematopoietic Cell Transplantation

Blood (2024) 144 (Supplement 1): 4866.

https://doi.org/10.1182/blood-2024-205070

Published: 2024

Journal Articles

A Simple Prediction Model of Outcomes after Allogeneic Hematopoietic Stem Cell Transplant (HCT) in Myelodysplastic Syndromes Using HCT-Comorbidity Index, Cytogenetic Risk, and Platelet Count

Blood (2023) 142 (Supplement 1): 2246.

https://doi.org/10.1182/blood-2023-185315

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Modal CAR T cells: A synthetic cytokine circuit to overcome TGFβ-mediated immunosuppression in AML

Development of a novel multiomic sequencing approach to characterize infused donor memory-like NK cells in an immune compatible environment

LIME: A first-in-class of live bacterial immune engagers for cancer immunotherapy

Primary results from Equator, a Phase 3 double-blind, randomized placebo-controlled study evaluating itolizumab in combination with corticosteroids as initial treatment of acute graft-versus-host disease.

Early TCR diversity and recipient stem-cell persistence predict relapse and reveal therapeutic targets after allogeneic transplantation

Reprogramming CAR-NK cells with IL-7/IL-7Rα to amplify STAT1 signaling and activate bystander T cells for enhanced immunotherapy

Overcoming CAR T cell resistance in NPM1c and KMT2Ar AML through menin pathway inhibition

Impact of graft versus host disease prophylaxis with post transplant cyclophosphamide on the prognostic value of HCT-CI

Effect of graft cellular content on outcomes in HLA mismatched hematopoietic cell transplantation using post-transplant cyclophosphamide

Donor regulatory/conventional T-cell grafts for the GVHD win?

Impact of Consolidative Cellular Therapy with DLI or Second Transplant in Patients with AML Who Achieve Complete Remission Following Post-Transplant Relapse

Heterogeneity of PD-1 + regulatory T Cells after Low-Dose IL-2 Therapy for Patients with Chronic Graft-Versus-Host Disease

Effects of GvHD Prophylaxis with Post-Transplant Cyclophosphamide on Immune Reconstitution and TCR Repertoire after Haploidentical and HLA-Matched Transplantation Compared to Prophylaxis with Calcineurin Inhibitor Plus Methotrexate in HLA-Matched Transplantation

Induction of Graft-Versus-Leukemia Effect with Treg-Depleted DLI Plus Ipilimumab for Myeloid Disease Relapse after HLA-Matched Transplant

BK Virus Reactivation and Disease after Allogeneic Hematopoietic-Cell Transplantation: A Natural History Study

Mesothelin Targeting IL12-Engineered CAR Memory-like NK Cells Demonstrate Promising Efficacy in Acute Myeloid Leukemia

Early CMV Viral Load Burden Predicts Late Clinically Significant CMV Infections in Patients Receiving Ptcy-Based Hematopoietic Cell Transplantation

Redefining Clinical Response Criteria in Myelodysplastic Syndromes to Better Forecast Post-Transplant Outcomes

Expression of HLA-B*35 Is Associated with an Increased Risk of CMV Viremia and Clinically Significant CMV Infection in Patients Receiving Ptcy-Based Hematopoietic Cell Transplantation

A Simple Prediction Model of Outcomes after Allogeneic Hematopoietic Stem Cell Transplant (HCT) in Myelodysplastic Syndromes Using HCT-Comorbidity Index, Cytogenetic Risk, and Platelet Count

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only